World Health Organization Sounds Concern Over Severe Lack of Weight-Loss Medications

Under 10% of individuals eligible to benefit from obesity jabs like Wegovy are able to get them, caution the global health agency as it releases its initial recommendations on the medications.

With in excess of 1,000,000,000 individuals worldwide now classified as obese, it is advocating for increased and just access to these injectable treatments.

According to forecasts, over two billion could be obese by 2030 unless action is taken.

"The new guidelines recognises that obesity is a long-term condition that can be treated with comprehensive and ongoing treatment," stated its chief Tedros Adhanom Ghebreyesus.

Significant expense, constrained manufacturing, and logistical bottlenecks are key obstacles to widespread availability to the treatments that can aid individuals in losing considerable body mass, explains the body.

GLP-1 Therapy Scarcity

Despite the present most optimistic outlook, the manufacturing of GLP-1 therapies would only suffice for approximately 100 million people – fewer than 10% of those who need them, according to the health organization.

The recommendation encourages nations and manufacturers to increase access, through strategies like patent sharing.

Exclusive production rights on semaglutide – the primary component of Novo Nordisk's Wegovy – is scheduled to end in several countries in 2026.

How Weight-Loss Jabs Work

GLP-1 drugs replicate a biological compound to delay gastric emptying, suppress the appetite and boost the sense of being full so users consume fewer calories.

Individuals typically start to lose weight after several weeks of beginning the regular doses.

Research points to patients may see weight return a year later of stopping the medication, because their usual food cravings resume.

To be above a healthy weight increases your chance for contracting medical conditions, including type 2 diabetes, cardiovascular issues, stroke, and certain malignancies.

Obesity affects individuals in every country and was linked to millions of deaths worldwide in 2024, as per the health agency.